Sort   by:  
 Page size 
UnknownRisk factors for GI adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced ovarian cancer: A Gynecologic Oncology Group Study.
Not available
S-EPMC3986384 | biostudies-literature
UnknownFertility in classical galactosaemia, a study of N-glycan, hormonal and inflammatory gene interactions.
Not available
S-EPMC6146524 | biostudies-literature
UnknownNeuroendocrine Differentiation in Prostate Cancer Requires ASCL1.
Not available
S-EPMC11534540 | biostudies-literature
UnknownPhylogeography and genetic ancestry of tigers (Panthera tigris).
Not available
S-EPMC534810 | biostudies-literature
UnknownEfficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis.
Not available
S-EPMC5559888 | biostudies-literature
UnknownStructures of the fungal dynamin-related protein Vps1 reveal a unique, open helical architecture.
Not available
S-EPMC6168280 | biostudies-literature
UnknownSalvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG.
Not available
S-EPMC8162056 | biostudies-literature
UnknownAchievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsis.
Not available
S-EPMC11018654 | biostudies-literature
UnknownEnhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia.
Not available
S-EPMC9203703 | biostudies-literature
UnknownMeeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting.
Not available
S-EPMC8442561 | biostudies-literature
Sort   by:  
 Page size